1. Phase II Study of Irinotecan plus S-1 in Treatment of Advanced Gastric Cancer
   Hideki Bou et al, 2013, Journal of Cancer Therapy CrossRef
2. Phase II Study of Docetaxel and S-1 Combination Therapy for Advanced or Recurrent Gastric Cancer
   Kazuhiro Yoshida et al, 2006, Clinical Cancer Research CrossRef
3. Phase I and Pharmacokinetic Study of the Oral Fluoropyrimidine S-1 on a Once-Daily-for-28-Day Schedule in Patients with Advanced Malignancies
   Quincy Siu-Chung Chu et al, 2004, Clinical Cancer Research CrossRef
4. The Outcome of Treatment for Patients with Borrmann Type 4 Advanced Gastric Cancer
   Rie Tamaki et al, 2016, Journal of Cancer Therapy CrossRef